In 2020, paediatric consumer health is expected to post a stronger current value growth rate than was seen in 2019. In fact, all subcategories, except for paediatric laxatives and digestive remedies, are expected to post stronger growth in 2020 in comparison to the previous year.
In 2020, paediatric analgesics continued to account for the majority of paediatric consumer health current value sales. Paediatric ibuprofen still represents the majority of current value sales of analgesics, distantly followed by paediatric acetaminophen and then paediatric aspirin.
Bayer continued to hold the leading value share in paediatric vitamins and dietary supplements in 2020, benefitting from increased consumption as a result of COVID-19. Its value share declined throughout the review period, and its value growth rate declined from 2013-2018.
Following the strong performance in 2020, paediatric consumer health is set to slightly slow in current value growth in 2021, and then sustain a stable rate of growth throughout the rest of the forecast period. The forecast current value CAGR is set to be slightly lower than that seen in the review period.
Over the forecast period, consumers are expected to increasingly turn to generic brands as they offer the same effectiveness of branded products, albeit usually at lower prices. Towards the end of the review period, demand for value-priced generic brands was strongly increasing in paediatric analgesics.
The Uruguayan Public Health Ministry has been very successful at highlighting the fact that essential vitamins can be easily found in readily available and often consumed foods, which might hamper growth of paediatric consumer health over the forecast period. The government has been heavily promoting awareness of what specific foods best provide healthy nutrition, and has not advertised the benefits of supplementing a healthy diet with vitamins.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Paediatric consumer health industry in Uruguay with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Paediatric consumer health industry in Uruguay, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Paediatric consumer health research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page